The report provides a detailed analysis essential for establishing a Metoprolol Succinate production plant. It encompasses all critical aspects necessary for Metoprolol Succinate production, including the cost of Metoprolol Succinate production, Metoprolol Succinate plant cost, Metoprolol Succinate production costs, and the overall Metoprolol Succinate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Metoprolol Succinate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Metoprolol succinate is a medicine that slows down the heart and relaxes blood vessels to treat high blood pressure, chest pain, and heart failure. It is used to manage hypertension as it lowers blood pressure by reducing heart rate and cardiac output. It decreases the risk of strokes, heart attacks, and kidney problems. It is used for treating people who suffer from long-term heart misfunctioning where the heart isn't pumping strongly. This drug helps to protect the heart from overworking and to heal better, reducing frequent visits to the hospital.
It is used to manage angina by decreasing the heart's oxygen demand and reducing the frequency and severity of chest pain. It also helps control certain types of arrhythmias by slowing the heart rate and stabilizing electrical activity. Also, it is utilized in post-myocardial infarction to reduce the risk of heart attacks and sudden cardiac death. It should be used cautiously because of potential side effects like fatigue, dizziness, and bradycardia.
The market for metoprolol succinate is driven by growing cases of cardiovascular diseases like hypertension, angina pectoris, and heart failure. Its availability as a cost-effective generic medication, as it is more accessible to a large number of patients, contributes to its market growth. The increase in the aged population that suffers from cardiovascular ailments further fuels its demand. Also, rising healthcare expenditure, along with growing public awareness of lifestyle-related diseases like obesity and diabetes, makes it a popular medication. Its availability as extended-release tablets with better distribution channels affects industrial metoprolol succinate procurement. North American region leads its market because of better technology and investments in healthcare. Altogether, these factors affect its prices and availability around the globe.
Raw Material for Metoprolol Succinate Production
According to the Metoprolol Succinate production plant project report, the key raw materials used in the production of Metoprolol Succinate include (4-Methoxy 2-Ethyl Phenol)-Epichlorohydrin- Monoisopropyl Amine.
Production Process of Metoprolol Succinate
The extensive Metoprolol Succinate production cost report consists of the following major industrial production process:
- From 4-Methoxy 2-Ethyl Phenol, Epichlorohydrin, and Monoisopropyl Amine: The production of metoprolol succinate involves a multi-step process. First, 4-Methoxy 2-Ethyl Phenol is dissolved in aqueous caustic soda and reacted with epichlorohydrin to produce metoprolol epoxide. Now, this metoprolol epoxide is reacted with monoisopropyl amine and water, followed by the removal of unreacted amine through distillation, forming a metoprolol base. Finally, the metoprolol base is combined with isopropyl alcohol, methanol, and succinic acid, forming metoprolol succinate.
Metoprolol succinate has the molecular formula of C34H56N2O10 and a molecular weight of 652.82 g/mol. It is a white crystalline powder and has a density of around 1.3 g/cm³. It is freely soluble in water and methanol, sparingly soluble in ethanol, and slightly soluble in dichloromethane and 2-propanol. It has a butanedioic acid moiety linked to the metoprolol molecule and has a pH stability between 4.5 and 7.0. It shows good thermal stability. It is available in extended-release formulation that provides a more stable beta1-blockade over 24 hours compared to immediate-release metoprolol. All these physical and chemical properties make it a useful formulation in pharmaceutical applications.